← Eichor
Study identifier: NCT06202404 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Predicting Tumor Metastasis by Employing a Target Organ/Primary Lesion Fusion Radiomics Model

Condition: Metastasis · Predictive Cancer Model  ·  Sponsor: Fudan University

PhaseN/A
Planned participants166
Who can joinAll sexes, 18 Years to 75 Years
Healthy volunteersNo

About this study

A pre-metastatic target organ/primary lesion fusion radiomics model was developed based on the "soil-seed" theory to predict comman tumor metastasis in retrospective settings. To prospectively verify the performance of the target organ/primary lesion fusion radiomics model in predicting tumor metastasis patterns (brain metastasis in lung cancer, liver metastasis in colorectal cancer, lung metastasis in breast cancer), we designed this prospective observational trial.

This description comes directly from the study's public registry record.

Talk to the study team

Xiao Chu  ·  15821383376  ·  chuxiao@sibs.ac.cn

Always discuss trial participation with your own doctor first.

Locations (2)

Fudan University Shanghai Cancer CenterShanghai, Shanghai Municipality, ChinaRecruiting
Fudan University Shanghai Cancer CenterShanghai, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06202404